Cargando…

Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates

Significant progress has already been made in development and testing of SARS-CoV-2 vaccines, and Phase III clinical trials have begun for 6 novel vaccine candidates to date. These Phase III trials seek to demonstrate direct benefits of a vaccine on vaccine recipients. However, vaccination is also k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallagher, Molly E., Sieben, Andrew J., Nelson, Kristin N., Kraay, Alicia N. M., Lopman, Ben, Handel, Andreas, Koelle, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430602/ https://www.ncbi.nlm.nih.gov/pubmed/32817958 http://dx.doi.org/10.1101/2020.08.07.20170456

Ejemplares similares

The role of booster vaccination and ongoing viral evolution in seasonal circulation of SARS-CoV-2
por: Kraay, A. N. M., et al.
Publicado: (2022)

Predicting indirect effects of rotavirus vaccination programs on rotavirus mortality among children in 112 countries
por: Kraay, A. N. M., et al.
Publicado: (2023)

Modeling serological testing to inform relaxation of social distancing for COVID-19 control
por: Kraay, Alicia N.M., et al.
Publicado: (2020)

Modeling serological testing to inform relaxation of social distancing for COVID-19 control
por: Kraay, Alicia N. M., et al.
Publicado: (2021)

Characterizing Norovirus Transmission from Outbreak Data, United States
por: Steele, Molly K., et al.
Publicado: (2020)

Decontamination of SARS-CoV-2 from cold-chain food packaging provides no marginal benefit in risk reduction to food workers
por: Sobolik, Julia S., et al.
Publicado: (2022)

Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies
por: Shioda, Kayoko, et al.
Publicado: (2020)

Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies
por: Shioda, Kayoko, et al.
Publicado: (2021)

The changing epidemiology of SARS-CoV-2
por: Koelle, Katia, et al.
Publicado: (2022)

Causes and Consequences of Spatial Within-Host Viral Spread
por: Gallagher, Molly E., et al.
Publicado: (2018)

Risk for Fomite-Mediated Transmission of SARS-CoV-2 in Child Daycares, Schools, Nursing Homes, and Offices
por: Kraay, Alicia N.M., et al.
Publicado: (2021)

Controlling risk of SARS-CoV-2 infection in essential workers of enclosed food manufacturing facilities
por: Sobolik, Julia S., et al.
Publicado: (2022)

Predicting norovirus and rotavirus resurgence in the United States following the COVID-19 pandemic: a mathematical modelling study
por: Lappe, Brooke L., et al.
Publicado: (2023)

Pregnant women's perceptions of risks and benefits when considering participation in vaccine trials
por: Jaffe, Elana, et al.
Publicado: (2020)

Reply to Park et al
por: Kraay, Alicia N M
Publicado: (2021)

Effect of Norovirus Inoculum Dose on Virus Kinetics, Shedding, and Symptoms
por: Ge, Yang, et al.
Publicado: (2023)

Controlling risk of SARS-CoV-2 infection in essential workers of enclosed food manufacturing facilities
por: Sobolik, Julia S., et al.
Publicado: (2021)

Recent Advances in High-sensitivity In Situ Hybridization and Costs and Benefits to Consider When Employing These Methods
por: Higo, Shimpei, et al.
Publicado: (2023)

Separate spheres and indirect benefits
por: Brock, Dan W
Publicado: (2003)

Meningeal tuberculoma: when to consider it?
por: Kitamura, Matheus Augusto Pinto, et al.
Publicado: (2021)

When Did HIV Incidence Peak in Harare, Zimbabwe? Back-Calculation from Mortality Statistics
por: Lopman, Ben, et al.
Publicado: (2008)

Should Heartbeats/Training Session Be Considered When Comparing the Cardiovascular Benefits of High-Intensity Interval Aerobic and Moderate-Intensity Continuous Training? A Critical Appraisal
por: Rodrigues, Jhennyfer Aline Lima, et al.
Publicado: (2020)

qPCR and qRT-PCR analysis: Regulatory points to consider when conducting biodistribution and vector shedding studies
por: Ma, Haiyan, et al.
Publicado: (2020)

Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?
por: Nelson, Kristin N, et al.
Publicado: (2023)

Consider your goals when writing
por: Canavor, Natalie, et al.
Publicado: (2010)

Mind the Mother When Considering Breastfeeding
por: Rivi, Veronica, et al.
Publicado: (2020)

484. The Impact of SARS-CoV-2 on Reproduction Rates of Seasonal Influenza and RSV
por: Sherman, Amy C, et al.
Publicado: (2020)

Semi-infectious particles contribute substantially to influenza virus within-host dynamics when infection is dominated by spatial structure
por: Farrell, Alex, et al.
Publicado: (2023)

Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections
por: Ben-Shachar, Rotem, et al.
Publicado: (2015)

Transmission-clearance trade-offs indicate that dengue virulence evolution depends on epidemiological context
por: Ben-Shachar, Rotem, et al.
Publicado: (2018)

An experimental test for indirect benefits in Drosophila melanogaster
por: Rundle, Howard D, et al.
Publicado: (2007)

Low risk of SARS-CoV-2 transmission via fomite, even in cold-chain
por: Sobolik, Julia S., et al.
Publicado: (2021)

Consider Culture When Implementing Agile Practices
por: Ramesh, Balasubramaniam
Publicado: (2018)

Ten simple rules when considering retirement
por: Bourne, Philip E.
Publicado: (2018)

When to consider lung transplantation for COVID-19
por: Cypel, Marcelo, et al.
Publicado: (2020)

Considering the Potential Benefits of Over-the-Counter Naloxone
por: Evoy, Kirk E, et al.
Publicado: (2021)

The benefit of considering others in individual health decisions
por: Sievert, Elisabeth D. C.
Publicado: (2023)

When Should Indirect Calorimetry Be Repeated To Measure Resting Energy Expenditure In Critically Ill Covid-19 Patients?
por: Valgaeren, E., et al.
Publicado: (2023)

Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?
por: Santoro, Francesco, et al.
Publicado: (2018)

Should the Human Microbiome Be Considered When Developing Vaccines?
por: Ferreira, Rosana B. R., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_leavs2bsff2q1j6ps5frj0qhge